Laurion Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Laurion Capital Management's GILD Position: Q2 2026 in Review
Laurion Capital Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 17,812 shares — an estimated $2.48M sold.
Laurion Capital Management first reported a position in GILD in Q4 2015 and held it in 23 quarters. The position peaked at $18.7M in Q1 2016. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Laurion Capital Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Laurion Capital Management sold 17,812 Gilead Sciences shares in Q2 2026, an estimated $2.48M.
- Laurion Capital Management first reported a position in Gilead Sciences in Q4 2015 and held it in 23 quarters.
- Laurion Capital Management's Gilead Sciences position peaked at $18.7M in Q1 2016.
- 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Laurion Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.